Shun Xu Selected Research

Circular RNA

5/2024	circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
1/2023	Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC.
1/2022	Circular RNA circRNF169 functions as a miR-30c-5p sponge to promote cellular senescence.
12/2021	circGNAQ, a circular RNA enriched in vascular endothelium, inhibits endothelial cell senescence and atherosclerosis progression.
1/2021	circRNA_141539 can serve as an oncogenic factor in esophageal squamous cell carcinoma by sponging miR-4469 and activating CDK3 gene.
12/2020	[Erratum] circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer.
1/2020	circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer.
1/2019	Research progress of circular RNAs in lung cancer.
1/2019	CircPUM1 promotes the malignant behavior of lung adenocarcinoma by regulating miR-326.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shun Xu Research Topics

Disease

39	Neoplasms (Cancer) 05/2024 - 07/2003
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 08/2013
11	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2014
8	Adenocarcinoma of Lung 09/2022 - 02/2009
7	Inflammation (Inflammations) 12/2022 - 01/2015
6	Neoplasm Metastasis (Metastasis) 10/2020 - 08/2013
5	Wounds and Injuries (Trauma) 01/2023 - 12/2007
5	Carcinogenesis 01/2020 - 01/2011
4	Burns 01/2023 - 12/2007
4	Myocardial Infarction 12/2022 - 06/2014
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 05/2018
3	Pathologic Processes 01/2023 - 01/2020
3	Neuroinflammatory Diseases 01/2022 - 10/2020
3	Lymphatic Metastasis 01/2020 - 02/2009
3	Human Influenza (Influenza) 01/2015 - 08/2013
2	Cicatrix (Scar) 11/2023 - 12/2007
2	Hypertrophic Cicatrix (Hypertrophic Scar) 11/2023 - 08/2008
2	Melanoma (Melanoma, Malignant) 07/2023 - 01/2018
2	Pain (Aches) 01/2023 - 04/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2018
2	Adenocarcinoma 01/2022 - 01/2020
2	Atherosclerosis 12/2021 - 01/2015
2	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2021
2	Esophageal Neoplasms (Esophageal Cancer) 12/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 12/2006
1	Deafness (Deaf Mutism) 02/2024
1	Cardiomyopathies (Cardiomyopathy) 02/2024
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2024
1	Starvation 01/2024
1	Intervertebral Disc Degeneration 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Unstable Angina 12/2022
1	Intraoperative Complications 01/2022
1	Heart Failure 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2006
9	Circular RNAIBA 05/2024 - 01/2019
9	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2015
6	Gefitinib (Iressa)FDA Link 11/2021 - 01/2018
5	MicroRNAs (MicroRNA)IBA 07/2018 - 01/2011
4	CytokinesIBA 07/2023 - 01/2018
4	Long Noncoding RNAIBA 03/2021 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2018
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2013
3	Hemagglutinins (Hemagglutinin)IBA 01/2015 - 08/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 08/2020
2	Cyclin D1IBA 07/2023 - 01/2019
2	Adenosine Diphosphate (ADP)IBA 03/2023 - 03/2023
2	EnzymesIBA 01/2023 - 01/2021
2	Calcium-Binding ProteinsIBA 11/2022 - 01/2021
2	Carcinoembryonic AntigenIBA 01/2022 - 01/2020
2	Toll-Like Receptor 4IBA 01/2022 - 10/2020
2	VaccinesIBA 11/2020 - 01/2015
2	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2018
2	Sincalide FDA Link 01/2020 - 01/2018
2	LigandsIBA 01/2020 - 02/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2015 - 12/2006
2	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2007 - 07/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2007 - 07/2007
1	osimertinibIBA 05/2024
1	myosin VIIBA 02/2024
1	NitrogenIBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	lathyraneIBA 11/2023
1	DiterpenesIBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 10/2023
1	Tumor Biomarkers (Tumor Markers)IBA 08/2023
1	VemurafenibIBA 07/2023
1	GalactosidasesIBA 07/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 03/2023
1	ChromatinIBA 01/2023
1	GlycolipidsIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	6-methyladenineIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 12/2022
1	Neurofibromin 1 (Neurofibromin)IBA 12/2022
1	UbiquitinIBA 12/2022
1	Interleukin-18 (Interleukin 18)IBA 11/2022
1	EphrinsIBA 09/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2022
1	antineoplaston A10 (A 10)IBA 09/2022
1	Methylcellulose (BFL)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022

Therapy/Procedure

15	Therapeutics 11/2023 - 11/2014
13	Drug Therapy (Chemotherapy) 08/2023 - 12/2009
5	Immunotherapy 08/2023 - 01/2018
3	Radiotherapy 08/2023 - 12/2009
3	Lymph Node Excision (Lymph Node Dissection) 11/2022 - 01/2020
2	Operative Surgical Procedures 08/2020 - 07/2003
2	Segmental Mastectomy (Lumpectomy) 08/2020 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2018 - 10/2011
2	Tracheostomy 07/2011 - 07/2003
2	Lung Transplantation 08/2007 - 07/2007
1	Organ Transplantation 01/2023
1	Patient Readmission 01/2022
1	Nephrectomy 01/2022